5 Wegovy Side Effects in Females You Shouldn’t Ignore

Certain factors make someone more likely to experience adverse drug reactions or side effects, including being female. Research shows that women are 1.5 to 1.7 times more likely than men to experience these reactions.

This matters especially when it comes to medications like Wegovy (semaglutide), which has gained significant attention as a weight-loss treatment. While its effectiveness is well-documented, many women using Wegovy report side effects that are often overlooked or misunderstood.

This guide explores the most relevant Wegovy side effects in females, backed by clinical research and real-world experiences. You’ll also learn what’s normal, when to be concerned, and how to respond.

Why Women May React Differently to Wegovy

Researchers aren’t entirely sure why, but factors may include:

Albumin Levels

Semaglutide is a large, peptide-based molecule that binds to albumin, a protein in the blood. This helps it circulate throughout the body in a stable and slow-releasing form. It mostly stays within the bloodstream rather than spreading widely into fat or muscle tissue.

Studies show that women’s albumin levels drop faster than men’s, but by age 60, male and female levels are nearly the same.

When albumin is low, more “free” (unbound) semaglutide may circulate in your blood. This might lead to faster clearance from your body or stronger short-term effects, since unbound drug is more biologically active.

However, differences in albumin levels between men and women haven’t been closely studied on their own in relation to semaglutide. So, the idea that it causes stronger short-term effects is still theoretical and hasn’t been confirmed in clinical trials.

Slower Gastric Emptying

One of the ways Wegovy helps with weight loss is by slowing how fast food leaves your stomach, called gastric emptying. This makes you feel full longer and reduces how much you eat.

However, if you have naturally delayed stomach emptying, adding Wegovy can:

• • Worsen symptoms like nausea, bloating, or early fullness
  • Increase the risk of vomiting or gastrointestinal discomfort
  • Potentially make it harder to tolerate the medication, especially during dose increases

A review of studies suggests that women have slower gastric emptying compared to men. This difference may be linked to higher levels of sex hormones and nitric oxide (NO). It’s also well known that women are more likely than men to develop gastroparesis (a condition where the stomach empties too slowly), but the reasons behind this difference are still not fully understood.

Hormonal Fluctuations

Hormonal fluctuations in women, particularly those related to estrogen and progesterone during menstrual cycles, pregnancy, perimenopause, or menopause, can influence how side effects from Wegovy are experienced.

One study looked at over 18 million reports from 1967 to January 2018, submitted from 131 countries. Researchers found that 60% of side effect reports involved females. This pattern began in adolescence (from age 12 to 17) and was most noticeable in women aged 18 to 44, which is the typical reproductive age range.

Reporting Behavior

Aside from biological differences between sexes, reporting behavior may partly explain why women report more side effects from Wegovy. Studies consistently show that women are:

• • More likely to notice and verbalize health changes.
  • More proactive in seeking medical help for side effects.
  • More engaged with online forums, support groups, and post-marketing reporting systems (like MedWatch or VigiBase).

Social conditioning often encourages women to be more aware of their health and more comfortable discussing bodily symptoms, especially with healthcare providers. Men, in contrast, may underreport due to stigma or the tendency to “tough it out.”

Commonly Reported Wegovy Side Effects in Females

While Wegovy’s side effects are generally similar across sexes, many women report certain symptoms more frequently or intensely. Below are the most commonly reported side effects among female users.

1. Changes in Menstrual Cycle

Some women report changes in their periods after starting Wegovy. These include irregular cycles, heavier or lighter bleeding, or even missed periods. For women with polycystic ovary syndrome (PCOS), these changes can be even more pronounced.

In a Reddit post, a 28-year-old woman who had been taking Wegovy for about 3.5 months began experiencing prolonged, heavy periods with clotting around the 6-week mark, which by the time of her post had lasted for three continuous weeks. She expressed concern and exhaustion over the nonstop bleeding and asked the community if anyone else had experienced similar effects.

Multiple women commented and reported experiencing unusually long, heavy, or painful periods after starting Wegovy.

• • One had previously gone years without a period, but after starting Wegovy, she bled consistently for nearly two months.

• • Another user, who normally had light periods due to a birth control implant, described experiencing her heaviest cycle ever after her Wegovy dose was increased.

• • Several noted increased clotting and cramping, even without major changes in diet or medication.

In another post, a 54-year-old woman shared her experience of what seemed like a return of menstruation after starting Wegovy. Though not officially postmenopausal (only 8 months without a period), she had clear menopausal symptoms, such as hot flashes, joint pain, dryness, and an absence of periods.

After beginning Wegovy, her hot flashes quickly disappeared, and soon after, she experienced discharge, migraines, and the return of her period, resembling her previous hormonal cycles. She reported this to her doctor, who acknowledged that other women were also experiencing hormonal changes and menstrual disruptions on GLP-1 medications like Wegovy.

While some theorized that rapid fat loss could be the cause, multiple users emphasized that these symptoms appeared early, before any major weight loss occurred.

Several women were sent for urgent gynecologic evaluations due to postmenopausal bleeding, including ultrasounds, biopsies, and hysteroscopies. While some found benign causes like fibroids or endometrial thickening, others had no underlying issue and still suspected Wegovy.

However, menstrual changes due to Wegovy can sometimes be a positive effect. Excess body fat often disrupts the normal balance of hormones, which can lead to irregular or absent menstrual periods. Wegovy helps with weight loss and improves insulin sensitivity, which in turn can restore hormonal balance and regular ovulation.

In one study, treatment with semaglutide led to a total weight loss of 11.5 kg, and BMI dropped from 34.4 to 29.4. About 80% of the participants regained normal menstrual cycles, suggesting that hormonal balance was improving.

Case Spotlight: Semaglutide for Severe Dysmenorrhea

In a case report, a 20-year-old woman with a 9-year history of severe menstrual symptoms experienced near-complete relief after starting compounded semaglutide at 0.25 mg twice monthly. She had no history of PCOS or other gynecological conditions and had previously been unresponsive to NSAIDs and other OTC pain medications. Her symptoms included:

• • Pelvic pain
  • Nausea
  • Vomiting
  • Fainting (syncope)

After initiating semaglutide, her pelvic pain significantly decreased, she required only two ibuprofen tablets during her last menstrual cycle, and the length of her menses shortened from seven to four days.

When she paused the medication for three months, all symptoms returned. Upon resuming treatment, she again experienced full symptom relief, supporting semaglutide as the likely source of improvement.

This case suggests a potential off-label use of semaglutide for managing treatment-resistant dysmenorrhea, though more research is needed.

2. Acne

Findings of an early study showed that GLP-1 users were 36% more likely to develop acne within 90 days of starting the medication, and 34% more likely after one year. When the data was broken down by sex, only women showed a significant increase, 53% more likely to develop acne after one year. Men had no increased risk.

Researchers suggest the cause may be hormonal. GLP-1 drugs stimulate growth hormone, which raises IGF-1 levels, a compound that increases sebum production and can trigger acne. Women with obesity, especially postmenopausal women, often have higher testosterone levels and more visceral fat, which may heighten their sensitivity to these hormonal shifts. Patients with hidradenitis suppurativa (HS) may be particularly prone to GLP-1-related acne.

A meta-analysis of 45 studies also found no clear evidence that GLP-1 drugs directly cause acne. Instead, hormonal shifts resulting from weight loss could have triggered or worsened acne in some individuals.

In another Reddit post, a 30-year-old woman shared her frustration about suddenly developing severe breakouts after four months on Wegovy (1 mg dose). She had never had skin issues before, not even as a teen, and was now experiencing acne clustered under her cheekbones. With no changes to her skincare, diet, or lifestyle, she suspected Wegovy might be the cause.

3. Hair Thinning or Shedding

Many women on Wegovy have reported increased hair shedding, especially after several months of treatment. In Wegovy’s clinical trials, up to 4% of participants reported hair loss, compared to about 1% in placebo groups.

Researchers at the University of British Columbia analyzed a large health insurance claims database with data from 1,926 people on semaglutide. They found that users on semaglutide were 52% more likely to report hair loss than those on bupropion-naltrexone (Contrave), another weight-loss drug. Women had double the risk of hair loss compared to men.

Experts say this is not surprising and likely related to:

• • Rapid weight loss, people who lost more than 20% of their body weight were more likely to experience this side effect
  • Changes in diet, vitamin intake, or deficiencies in important nutrients like iron, zinc, vitamin D, and biotin
  • Physiological stress the body experiences during major weight loss

Doctors say this type of hair loss is usually temporary, known as telogen effluvium, and may improve as the person’s weight and health stabilize.

However, in one case report, semaglutide might have triggered alopecia areata (an autoimmune hair loss condition) in a patient, though a direct causal link can’t be confirmed. The patient had their dose increased to 0.5 mg weekly. Soon after, they began noticing a small round patch of hair loss on the crown of the head.

4. Mood Changes or Irritability

The exact reason why Wegovy may cause psychiatric side effects is still under investigation, but researchers and clinicians have proposed several possible explanations, including:

• • Biological effects on brain signaling,
  • Rapid body and metabolic changes, and
  • Existing mental health vulnerabilities.

Novo Nordisk, the manufacturer of Wegovy, has already advised doctors to warn patients about the potential for depression, suicidal thoughts or behavior, and any unusual mood changes. Anxiety has also been listed as a side effect and was reported in up to 4% of clinical trial participants.

Researchers analyzed safety reports submitted to EudraVigilance, the European database for tracking medication side effects, from January 2021 to May 2023. Among the psychiatric cases reported:

• • Depression accounted for 50%
  • Anxiety was reported in 39%
  • Suicidal thoughts occurred in nearly 20%

There were 11 life-threatening cases, including 7 linked to semaglutide. Although about 65% of the reports involved female patients, the fatal outcomes occurred primarily in men.

Case Spotlight: Depression Relapse After Starting Semaglutide

This report describes a 40-year-old woman with a long history of recurrent major depressive disorder. To help with her blood sugar and weight, her endocrinologist added semaglutide to her treatment in late March 2023, starting at 0.25 mg weekly, then increasing to 0.5 mg.

In late April, her mood began to worsen. Then in May, she developed fatigue, cognitive slowing, oversleeping, and suicidal thoughts, which resembled previous depressive episodes. These changes occurred despite prior successful psychotherapy. She also had personal stress (disagreements with her mother), but that alone hadn’t triggered such a decline before.

Within two weeks of stopping semaglutide, her mood began improving.

5. Breast Tenderness or Changes

Though rare, some women report breast tenderness or changes while taking Wegovy. These could be influenced by shifts in estrogen levels due to weight loss or altered metabolism, particularly in premenopausal or perimenopausal women.

While no studies confirm this side effect directly, anecdotal reports suggest a potential link.

In a Reddit post, a user who had been on Wegovy but temporarily switched to Ozempic due to supply issues, resumed Wegovy, and they noticed significant breast tenderness, similar to sensations during pregnancy or breastfeeding, which they had not experienced previously.

Supplements That May Support Women on Wegovy (With Caution)

Some women benefit from targeted supplementation to counteract Wegovy-related effects. While you should always consult your doctor before starting any new supplements, the following may help support metabolism, hair health, and hormonal balance during weight loss:

Final Thoughts

Women often react differently to Wegovy due to a mix of biological and hormonal factors. Common issues include changes in your menstrual cycle, acne, hair thinning, irritability, and breast tenderness. Some women also experience emotional shifts or worsened anxiety and depression. These effects aren’t always listed on the label, but they’ve been widely reported by other users and observed in real-world data.

If you’re on Wegovy and notice any of these symptoms, track them and talk to your doctor. Don’t ignore changes in your body. Early action can help you stay on track safely.

Frequently Asked Questions